BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 10874535)

  • 21. The role of apoptosis in thyroid autoimmunity.
    Wang SH; Baker JR
    Thyroid; 2007 Oct; 17(10):975-9. PubMed ID: 17900237
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Cytofluorometric analysis of chosen markers of apoptosis CD95/CD95L (Fas/FasL) in thyroid tissues from young patients with Graves' disease and Hashimoto's thyroiditis].
    Bossowski A; Stasiak-Barmuta A; Czarnocka B; Urban M; Łyczkowska A; Niedziela M; Bardadin K; Czerwińska J; Dadan J; Baltaziak M
    Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2006; 12(2):83-90. PubMed ID: 16813711
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of intercellular adhesion molecule-1 in thyroid follicular cells in autoimmune, non-autoimmune and neoplastic diseases of the thyroid gland: discordance with HLA.
    Tolosa E; Roura C; Catálfamo M; Martí M; Lucas-Martín A; Sanmartí A; Salinas I; Obiols G; Foz-Sala M; Pujol-Borrell R
    J Autoimmun; 1992 Feb; 5(1):107-18. PubMed ID: 1348415
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Untangling thyroid autoimmunity through modeling and simulation.
    Merrill SJ; Pandiyan B
    Front Biosci (Landmark Ed); 2018 Jun; 23(10):1889-1901. PubMed ID: 29772535
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Thyroid Autoimmunity: An Interplay of Factors.
    Merrill SJ; Minucci SB
    Vitam Horm; 2018; 106():129-145. PubMed ID: 29407432
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of apoptotic proteins in thyroid gland from patients with Graves' disease and Hashimoto's thyroiditis.
    Bossowski A; Czarnocka B; Bardadin K; Stasiak-Barmuta A; Urban M; Dadan J; Ratomski K; Bossowska A
    Autoimmunity; 2008 Mar; 41(2):163-73. PubMed ID: 18324486
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Detection and localization of chemokine gene expression in autoimmune thyroid disease.
    Kemp EH; Metcalfe RA; Smith KA; Woodroofe MN; Watson PF; Weetman AP
    Clin Endocrinol (Oxf); 2003 Aug; 59(2):207-13. PubMed ID: 12864798
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Clinical studies on autoimmune mechanisms of the thyroid Part II. Leucocyte migration inhibiton studies in Hashimoto's thyroiditis and in Graves' disease (author's transol)].
    Ikekubo K
    Nihon Naibunpi Gakkai Zasshi; 1975 Oct; 51(10):840-55. PubMed ID: 1243915
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Models to study the pathogenesis of thyroid autoimmunity.
    Krogh Rasmussen A; Hartoft-Nielsen ML; Feldt-Rasmussen U
    Biochimie; 1999 May; 81(5):511-5. PubMed ID: 10403183
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Assays of TSH-receptor antibodies in 576 patients with various thyroid disorders: their incidence, significance and clinical usefulness.
    Macchia E; Concetti R; Borgoni F; Cetani F; Fenzi GF; Pinchera A
    Autoimmunity; 1989; 3(2):103-12. PubMed ID: 2577491
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression and function of multiple regulators of complement activation in autoimmune thyroid disease.
    Tandon N; Yan SL; Morgan BP; Weetman AP
    Immunology; 1994 Apr; 81(4):643-7. PubMed ID: 7518800
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immune-endocrine interactions in autoimmune thyroid diseases.
    Klecha AJ; Barreiro Arcos ML; Frick L; Genaro AM; Cremaschi G
    Neuroimmunomodulation; 2008; 15(1):68-75. PubMed ID: 18667802
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association between breast cancer and autoimmune thyroid disorders: no increase of lymphocytic infiltrates in breast malignant tissues.
    Fierabracci P; Pinchera A; Campani D; Pollina LE; Giustarini E; Giani C
    J Endocrinol Invest; 2006 Mar; 29(3):248-51. PubMed ID: 16682839
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Leukocyte migration test (LMT) in patients with thyroid disease: the response to human thyroid subcellular fractions.
    Galluzzo A; Filardo C; Giordano C; Sparacino G; Bompiani GD
    J Endocrinol Invest; 1981; 4(2):173-6. PubMed ID: 6895083
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Up-regulated beta1-integrin expression in autoimmune thyroid disorders.
    Marazuela M; De Landázuri MO; Larrañaga E; Sánchez-Madrid F
    Clin Exp Immunol; 1997 Jul; 109(1):107-15. PubMed ID: 9218832
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diseases associated with thyroid autoimmunity: explanations for the expanding spectrum.
    Weetman AP
    Clin Endocrinol (Oxf); 2011 Apr; 74(4):411-8. PubMed ID: 20718761
    [TBL] [Abstract][Full Text] [Related]  

  • 37. No association of two Fas gene polymorphisms with Hashimoto's thyroiditis and Graves' disease.
    Stuck BJ; Pani MA; Besrour F; Segni M; Krause M; Usadel KH; Badenhoop K
    Eur J Endocrinol; 2003 Nov; 149(5):393-6. PubMed ID: 14585083
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Thyroid autoimmune disorders and cancer.
    Ferrari SM; Fallahi P; Elia G; Ragusa F; Ruffilli I; Paparo SR; Antonelli A
    Semin Cancer Biol; 2020 Aug; 64():135-146. PubMed ID: 31158464
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Perforin expression by thyroid-infiltrating T cells in autoimmune thyroid disease.
    Wu Z; Podack ER; McKenzie JM; Olsen KJ; Zakarija M
    Clin Exp Immunol; 1994 Dec; 98(3):470-7. PubMed ID: 7994911
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pathomorphological and immunohistochemical analysis of autoimmune processes in the thyroid gland.
    Androsova DS; Barakat MY; Pruglo YV
    Bull Exp Biol Med; 2007 Jun; 143(6):757-61. PubMed ID: 18239821
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.